KATIE MCLAUGHLIN: Open Payments
NPI 1891101838 · FRIDLEY, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 12 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $148 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Zimmer Biomet Holdings, Inc. | 1 | $143 |
| Iovance Biotherapeutics, Inc. | 2 | $40 |
| Kite Pharma, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| Stemline Therapeutics Inc. | 1 | $15 |
| Incyte Corporation | 1 | $14 |
Products named: ROSA, Amtagvi, Yescarta, Polivy, Enhertu, VENCLEXTA, Trodelvy, Orserdu.
Industry payments across MN — which companies pay providers there.
